CHPA Takes Position on Methamphetamine Problem

Published Online: Saturday, January 1, 2005

The President of the Consumer Healthcare Products Association (CHPA) is advocating for a comprehensive methamphetamine solution. CHPA President Linda A. Suydam, DPA, recently testified before the US House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources.

Although pseudoephedrine is a nonprescription nasal decongestant used safely and effectively to treat cold, allergy, and flu symptoms, Suydam noted the industry's strong concern that the ingredient can be illegally obtained and used with other products to manufacture the illegal drug methamphetamine. At the hearing entitled "Law Enforcement and the Fight Against Methamphetamine," Suydam recommended the following:

  • Limit the number of packages of medicines with pseudoephedrine a consumer can purchase at a time
  • Require registration of all retailers selling pseudoephedrine products
  • Enact severe penalties for those manufacturing and selling methamphetamine, especially those endangering children with illegal activities

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues